POST-ACUTE COVID-19

Clinical trials for POST-ACUTE COVID-19 explained in plain language.

Never miss a new study

Get alerted when new POST-ACUTE COVID-19 trials appear

Sign up with your email to follow new studies for POST-ACUTE COVID-19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2 Completed 1

Can a drug calm long COVID's lung inflammation? new trial aims to find out

Disease control Recruiting now

This study tests if the drug anakinra can help people with long COVID who have ongoing breathing issues and signs of an overactive immune system. About 182 adults will receive either anakinra or a placebo for up to 8 weeks. The goal is to see if the drug improves lung function, r…

Matched conditions: POST-ACUTE COVID-19

Phase: PHASE2, PHASE3 • Sponsor: Hellenic Institute for the Study of Sepsis • Aim: Disease control

Last updated Jun 27, 2026 08:09 UTC

POST-ACUTE COVID-19

Get alerted when new POST-ACUTE COVID-19 trials appear

Can a drug calm long COVID's lung inflammation? new trial aims to find out